firstname.lastname@example.org) of Genesis Diagnostics Ltd.
Press Release: Genesis Diagnostics Ltd, Cambridge, UK have announced the development of a new and sensitive test for celiac disease. The test will be available through hospital laboratories. The test is based on detecting antibodies to an enzyme called transglutaminase in blood. The new test is more specific for celiac than currently available tests and should result in speedier diagnosis.
Genesis Diagnostics is a manufacturer of ELISA based kits for autoimmune diagnosis. We already produce kits for gliadin IgG and IgA antibodies, which have been used for the past 5 years as the main test for celiac disease. The new test for transglutaminase was an obvious development of our experience in this area. We will continue to develop and improve blood tests in this area.
We will be seeking FDA approval for the transglutaminase test kit in 1999. In the mean time it can be used for research only.